SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : wla(warner lambert) -- Ignore unavailable to you. Want to Upgrade?


To: Matthew Tyson who wrote (163)12/9/1997 6:53:00 PM
From: Henry Niman  Respond to of 942
 
GLX has TZD programs for insulin resistance as well as energy metabolism. I wouldn't be surprised if their own programs influenced how they viewed the side effects associated with Rezulin.



To: Matthew Tyson who wrote (163)12/13/1997 10:31:00 AM
From: cirrus  Respond to of 942
 
It seems some institution dumped a whole lot of shares the past 10 days. I can't believe the Troglitazone issue is the only reason.